Stacey Jennifer Evans Stock Option Grant

Stacey Jennifer Evans, a director at Context Therapeutics Inc. (CNTX), was granted a stock option on June 24, 2026, to purchase 45,000 shares of common stock at an exercise price of $0.576 per share. The option vests on the earlier of June 24, 2027, or the company's 2027 annual meeting, contingent upon continued service. The option has an expiration date of June 23, 2036. This transaction is reported on Form 4.